Latest News

  • Kalbe Holds HJ Learning Forum

    Clinic Management in the JKN Area

    Sunday, July 22, 2018
    Kalbe Holds HJ Learning Forum

    Surabaya, 22 July 2018 – PT Hexpharm Jaya (HJ), a subsidiary of PT Kalbe Farma Tbk (Kalbe) holds the HJ Learning Forum (HJLF) with the theme of “Clinic Management Talk”. The event, held at Hotel Grand Mirama Mercure, was attended by more than 150 General Practitioners and Specialists from East Java. The educational event was opened by dr. Nur Haji the Chairman of the Indonesian Medical Association of East Java, and Sri Wiyanti, Group Product Manager of PT Hexpharm Jaya.

  • Kalbe Joined University of Surabaya Inaugurated Tissue Culture Laboratory

    Increasing the Quality and Use of Medicinal Plants For the Independence of Domestic Industry

    Wednesday, July 18, 2018
    Kalbe Joined University of Surabaya Inaugurated Tissue Culture Laboratory

    Surabaya, 18 Juli 2018 – PT Kalbe Farma Tbk (Kalbe) today through its subsidiary, PT Bintang Toedjoe, in collaboration with University of Surabaya (Ubaya) and Hanbang Bio (Kyung Hee University) South Korea, inaugurated the tissue culture laboratory that is located at the Biotechnology Faculty, Campus II, University of Surabaya. The Director of Development of Industrial Technology of the Ministry of Research, Technology, and Higher Education; Dr. Eng. Hotmatua Daulay, M.Eng., B.Eng.; inaugurated the laboratory accompanied by the President Director of PT Kalbe Farma Tbk., Vidjongtius along with the Rector of the University of Surabaya Prof. Ir. Joniarto Parung, MMBAT., PhD and Prof. Deok-Chun Yang, President Director of Hanbang Bio Co. Ltd (Kyung Hee University)

  • Kalbe Holds HJ Learning Forum

    Clinic Management in the JKN Area

    Sunday, July 8, 2018
    Kalbe Holds HJ Learning Forum

    Bandung, 8 July 2018 – PT Hexpharm Jaya (HJ), a subsidiary of PT Kalbe Farma Tbk (Kalbe) holds the HJ Learning Forum (HJLF) with the theme of “Clinic Management Talk”. The event, held at Hotel Mercure, was attended by more than 120 General Practitioners and Specialists from West Java.

  • Kalbe Group Holds Laboratory Diagnostic Discussion

    Quality Solutions in Answering Challenges in Public Services

    Saturday, July 7, 2018
    Kalbe Group Holds Laboratory Diagnostic Discussion

    Jakarta, July 7, 2018 - PT Kalbe Farma Tbk (Kalbe) through its subsidiary PT Enseval Medika Prima (EMP) organized a scientific discussion with the theme Solution for a Better Quality and Cost Control for Better Patient Outcome. The discussion is also used to introduce the Werfen brand to the clinical laboratory clinics in Indonesia as it has officially appointed EMP to be its sole distributor.

  • Kalbe to Distribute Dividend of Rp 1.17 Trillion

    Tuesday, June 5, 2018

    Jakarta, June 5, 2018 – PT Kalbe Farma Tbk (“Kalbe” or “the Company”) will distribute cash dividend of Rp 1.17 trillion. The dividend distribution of Rp 25 per share or equivalent to a dividend payout ratio of around 49% of fiscal year 2017 net income, has been approved by the shareholders of the Company in the Annual General Meeting of Shareholders (“AGMS”) held on June 5, 2018 in Gedung Bintang Toedjoe, Pulomas, Jakarta. In compliance with the prevailing regulations, dividend payment will be made at the latest within 30 days after the announcement of AGMS where the Company will shortly announce the schedule and procedures.

RSS
First34567Last